Cite
HARVARD Citation
Riudavets, M. et al. (2022). Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. European journal of cancer. pp. 142-148. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Riudavets, M. et al. (2022). Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. European journal of cancer. pp. 142-148. [Online].